One important consequence of the chimeric RNA is that MUC1-TRIM46-KRTCAP2 acquires a new 3’UTR that is lacking the binding site targeted by miR-145, a well-known tumor suppressor that inhibits invasion by silencing MUC1 through binding to its 3’ UTR [19]. Here, KRTCAP2 is linked to neoplasm.